比較肝素與0.9%生理食鹽水於成年人族群之中央靜脈導管的間歇性封管使用是否能有效預防管道阻塞

López-Briz E, Ruiz Garcia V, Cabello JB, Bort-Martí S, Carbonell Sanchis R, Burls A. Heparin versus 0.9%sodium chloride locking for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No.: CD008462. DOI: 10.1002/14651858.CD008462.pub3.

Smith RN. Central venous catheters. British Medical Journal 2013;347:f6570. DOI: 10.1136/bmj.f6570

Burns KE, McLaren A. A critical review of thromboembolic complications associated with central venous catheters. Canadian Journal of Anaesthesia 2008;55(8):532–41.

Google Scholar

Joks,M, Czyż A, Popławski D, Komarnicki M. Incidence and risk factors for central venous catheter-related thrombosis in hematological patients. Medical Oncology. 2014; 31(1): 772.

Google Scholar

Mermel LA. Prevention of intravascular catheter-related infections. Annals of Internal Medicine 2000;132(5): 391-402.

Google Scholar

延伸閱讀

李宇騰（2010）。單劑量低分子量肝素應用於長期規則血液透析病患療效及安全性評估〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-1208201016033300
邵偉城（2012）。環利尿劑與加護病房中常用靜脈注射藥之物理不相容性研究〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2012.03357
Lin, K. H., Shih, B. F., Tsao, C. H., & Wu, M. C. (2005). 續發於Methotrexate化學治療的肝毒性導致骨骼掃描廣泛肝臟鎝－99m-MDP攝取. 核子醫學雜誌, 18(2), 111-115. https://doi.org/10.6332/ANMS.1802.006
吳其諦（2013）。肝素對於十八歲以下族群預防導管相關性血流感染成效之統合分析〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://doi.org/10.6832/KMU.2013.00018
Naoum, J. J., Chamoun, N. R., Patel, M. S., Street, T. K., Haydar, M., Bismuth, J., Sayed, H. E., Davies, M. G., Lumsden, A. B., & Peden, E. K. (2014). Elevated Heparin-Induced Antibodies Are More Common in Diabetic Patients with Vascular Disease. Thrombosis, (2014), d1-5. https://doi.org/10.1155/2014/649652

國際替代計量

比較肝素與0.9%生理食鹽水於成年人族群之中央靜脈導管的間歇性封管使用是否能有效預防管道阻塞

全文下載

主題瀏覽